Ms. Iurkova is experienced in brand promotion, business development, marketing communications, and public relations. Prior to becoming Business Development Director for BIOMEDICA CRO, Iryna worked at Deloitte, Bayer, and AB InBev. She has a Master’s Degree in International Business Management. For the last seven years, Iryna has successfully worked in the field of human biospecimens, managing numerous complex projects.
Cooperation with BIOMEDICA CRO team during wartime – stand with Ukraine!
Dear colleagues, partners, and clients, As...
Gynecological specimens by BIOMEDICA CRO and bacterial vaginosis treatment strategy
Gynecological specimens research and new bact...
New approach of Breast Cancer treatment and BIOMEDICA CRO role
For years, researchers at Huntsman Cancer Ins...
Tumor samples research for ovarian cancer treatment – the review of novel imaging technology
Examining the secret hideouts of ovarian canc...
New predictions for multi-cancer early detection via microsatellite instability (MSI) testing
Researchers plan to adopt the Promega LMR MSI...
COVID-associated biospecimens & vaccines development – let`s stop the pandemic together
COVID-associated biospecimens for vaccines de...
The importance of clinical and preclinical trials for patients with chronic lymphocytic leukemia (CLL) – Patients Deserve More
The importance of clinical and preclinical tr...Biospecimen collection needed? YOU focus on science, we at BIOMEDICA CRO do the rest
Human biospecimen collection by BIOM...
